He did the same thing with Lympro. He could have partnered it. $50k silver sponsorship? That should have been a red flag for me and I am kicking myself about not jumping at the time. Relatively big companies don't pay that. Anyway, he could have partnered Lympro and Eltoprazine, bought ESS with the money, partnered ESS, and then sign a partner for one MANF indication. They could have used money from partnering to seek other products or develop other MANF indications. This whole thing is ridiculous and GC keeps getting paid. Beyond bizarre.
(14)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links